-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting Sumoylation Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
Friday, December 8, 2023, 3:29 PM-4:14 PM

Li Du, PhD

Judy and Bernard Briskin Center for Multiple Myeloma Research, Beckman Research Institute City of Hope, Duarte, CA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA; Toni Stephenson Lymphoma Center, Beckman Research Institute City of Hope, Duarte, CA

Disclosures: No relevant conflicts of interest to declare.

See more of: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation